• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.
Rchr
J-GLOBAL ID:201701010450415622   Update date: Jan. 07, 2025

Funakoshi Yohei

Funakoshi Yohei | Funakoshi Yohei
Affiliation and department:
Job title: Associate Professor
Research field  (4): Immunology ,  Hematology and oncology ,  Tumor diagnostics and therapeutics ,  Tumor biology
Research theme for competitive and other funds  (11):
  • 2024 - 2027 BCRレパトア解析を用いた造血幹移植後免疫再構築の解明
  • 2023 - 2027 B細胞を軸とした免疫チェックポイント阻害の有害事象の包括的機序解明と効果の推定
  • 2025 - 2026 抗原受容体をバイオセンサとする網羅的免疫反応評価
  • 2023 - 2025 Establishment of a platform for high-throughput CAR-T cell generation for gastric cancer
  • 2022 - 2025 Development of novel cancer immunotherapies targeting functional MDSCs
Show all
Papers (85):
  • Yoshiaki Nagatani, Naomi Kiyota, Yoshinori Imamura, Taiji Koyama, Yohei Funakoshi, Masato Komatsu, Tomoo Itoh, Masanori Teshima, Ken-Ichi Nibu, Kazuko Sakai, et al. Different characteristics of the tumor immune microenvironment among subtypes of salivary gland cancer. Asia-Pacific journal of clinical oncology. 2024
  • T. Koyama, N. Kiyota, S. Boku, Y. Imamura, N. Shibata, H. Satake, K. Tanaka, H. Hayashi, T. Onoe, Y. Asada, et al. Corrigendum to ‘A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody’: [ESMO Open volume 9 issue 6 (2024) 103476] (ESMO Open (2024) 9(6), (S2059702924012456), (10.1016/j.esmoop.2024.103476)). ESMO Open. 2024. 9. 8
  • Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Takaji Matsutani, Kazuhiko Doi, Hironori Sakai, Tomoki Sasaki, Takahiro Kusakabe, Sakuya Matsumoto, Yasuyuki Saito, et al. Analysis of B-cell receptor repertoire to evaluate immunogenicity of monovalent Omicron XBB.1.5 mRNA vaccines. EJHaem. 2024. 5. 4. 661-668
  • T. Koyama, N. Kiyota, S. Boku, Y. Imamura, N. Shibata, H. Satake, K. Tanaka, H. Hayashi, T. Onoe, Y. Asada, et al. A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody. ESMO Open. 2024. 9. 6
  • 今村 善宣, 能勢 拓, 大幡 真也, 乙井 一典, 森 健太, 辻 高寛, 宮田 吉晴, 金原 史朗, 長谷 善明, 小山 泰司, et al. 進行・再発・転移の固形腫瘍における血栓塞栓症と出血リスク PROVE-emboli試験post-hoc解析. 日本血栓止血学会誌. 2024. 35. 2. 336-336
more...
MISC (62):
  • 今村 善宣, 能勢 拓, 大幡 真也, 乙井 一典, 森 健太, 辻 高寛, 宮田 吉晴, 金原 史朗, 長谷 善明, 小山 泰司, et al. 進行・再発・転移の固形腫瘍における血栓塞栓症と出血リスク PROVE-emboli試験post-hoc解析. 日本血栓止血学会誌. 2024. 35. 2. 336-336
  • 長谷 善明, 船越 洋平, 南 博信. 進行胃癌に対する免疫療法と分子標的治療の新展開 びまん性胃癌における遺伝子変異と腫瘍免疫微小環境から考える複合免疫療法. 日本消化器病学会雑誌. 2024. 121. 臨増総会. A51-A51
  • 長谷善明, 船越洋平, 南博信. びまん性胃癌における遺伝子変異と腫瘍免疫微小環境から考える複合免疫療法. 日本消化器病学会雑誌(Web). 2024. 121
  • 船越佑大, 神田壮平, 秋濱晋, 堀川洋平, 東海林琢男, 下田直威. A CASE OF INFLAMMATORY MYOFIBROBLASTIC TUMOR OF THE BLADDER TREATED WITH PARTIAL CYSTECTOMY. 泌尿器科紀要. 2023. 69. 7. 179-182
  • 今村 善宣, 能勢 拓, 大幡 真也, 森 健太, 乙井 一典, 宮田 吉晴, 金原 史朗, 長谷 善明, 小山 泰司, 船越 洋平, et al. 進行・再発・転移の未治療固形がん患者における静脈血栓塞栓症の前向き観察研究の統合解析. 日本血栓止血学会誌. 2023. 34. 2. 195-195
more...
Lectures and oral presentations  (21):
  • Increase in Antibody Titers Following Sars-Cov-2 Vaccination Remains Limited for More Than 3 Years after Final Dose of Anti-CD20 Antibody
    (63rd ASH Annual Meeting 2021)
  • Relationship between tumor burden to growth rate and treatment outcomes of nivolumab for patients with head and neck squamous carcinoma.
    (ASCO-SITC 2019)
  • TP-0903, a multikinase inhibitor of AXL/JAK2/Aurora B, reduces inflammatory breast
    (2018San Antonio Breast Cancer Symposium 2018)
  • 肺動脈原発内膜肉腫の3例
    (第1回日本腫瘍循環器学会学術集会 2018)
  • 本邦での大腸癌患者におけるマイクロサテライト不安定性検査の有用性についての検討
    (第77回日本癌学会学術集会 2018)
more...
Education (2):
  • - 2013 Kobe University Graduate School of Medicine
  • 1998 - 2004 Nihon University School of Medicine
Professional career (1):
  • 博士(医学) (神戸大学)
Work history (2):
  • 2017/04 - 現在 神戸大学医学部附属病院
  • 2015/04 - 2017/03 MD Anderson Cancer Center Breast Medical Oncology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page